Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells (2017)
- Authors:
- Autor USP: SILVA, DENISE DE OLIVEIRA - IQ
- Unidade: IQ
- DOI: 10.1039/c7nr01582h
- Subjects: NANOPARTÍCULAS; NEOPLASIAS PROSTÁTICAS; NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RICO, Samara Rodrigues Alves et al. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale, v. 9, n. 30, p. 10701-10714, 2017Tradução . . Disponível em: https://doi.org/10.1039/c7nr01582h. Acesso em: 27 jan. 2026. -
APA
Rico, S. R. A., Abbasi, A. Z., Ribeiro, G., Ahmed, T., Wu, X. Y., & Silva, D. de O. (2017). Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells. Nanoscale, 9( 30), 10701-10714. doi:10.1039/c7nr01582h -
NLM
Rico SRA, Abbasi AZ, Ribeiro G, Ahmed T, Wu XY, Silva D de O. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells [Internet]. Nanoscale. 2017 ; 9( 30): 10701-10714.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1039/c7nr01582h -
Vancouver
Rico SRA, Abbasi AZ, Ribeiro G, Ahmed T, Wu XY, Silva D de O. Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells [Internet]. Nanoscale. 2017 ; 9( 30): 10701-10714.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1039/c7nr01582h - Thermodynamics of axial substitution and kinetics of reactions with amino acids for the paddlewheel complex tetrakis(acetato)chloridodiruthenium(II,III)
- A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
- Preparação de microesferas de quitosana reticulada e adsorção de um metalofármaco de cobre-naproxeno
- Estudo da viabilidade do uso de biopolímeros para o encapsulamento de um metalofármaco anti-inflamatório de cobre-ibuprofeno
- TGA/DSC characterization and drug release studies for a biocompatible material containing the drug ibuprofen encapsulated into polymeric cellulose acetate
- Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy
- Novel (μ-oxo)bis(μ-ibuprofenato)diruthenium(III) complexes derived from the reaction of the paddlewheel structured diruthenium-ibuprofen anticancer metallodrug with imidazole and 2-methyl-imidazole
- Estudos preliminares da interação entre um metalofármaco antiinflamatório de cobre-ibuprofeno e o biopolímero quitosana
- A novel potential antitumor metallodrug of ruthenium-fenbufen: characterization and reactivity with amino acids
- Estudo da influência do PH no comportamento do complexo tetraquis(acetato)cloridodirutênio (II, III)
Informações sobre o DOI: 10.1039/c7nr01582h (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
